Evidence map›Paper›PMID 42810225›Full record

ReviewCurrent opinion in chemical biology2026

Advances in the DMSO reductase family: From discovery to mechanism.

Nitai C Giri, Partha Basu

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nitai C GiriDepartment of Chemistry and Chemical Biology, Indiana University Indianapolis, IN, USA.
Partha BasuDepartment of Chemistry and Chemical Biology, Indiana University Indianapolis, IN, USA. Electronic address: basup@iu.edu.

Funding

Investigation of the Molybdenum Cofactor through Chemical, Biochemical and Biophysical StudiesR15GM139064 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI BASU, PARTHA · 2020 to 2024
$934k
NIGMS NIH HHS R15 GM139064
6 · The paper itself

Abstract

DMSO reductase (DMSOR) family found in prokaryotes is the most diverse group of molybdenum cofactor (Moco) containing enzymes from the structural as well as the catalytic viewpoints. While DMSOR, the prototype member of its family, is well characterized thanks to decades of rigorous research, a large majority of this family are yet to be characterized. These enzymes are important in biogeochemical cycles, biotechnology and health. With the discovery of new DMSOR family members, the family continues to grow further underscoring their importance. This review will focus on the latest developments in the DMSOR reductase family.

Indexed as

Atom transferDehydroxylaseMolybdenum cofactorOxidaseReductase

Identifiers

PMID42810225
PMCPMC13625933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.